Key takeaways
- Saudi Arabia ranks high on digital health engagement — 78% of consumers track their health digitally against a global average of 57%, driven by one of the region’s highest burdens of lifestyle-related chronic conditions, with 23.1% of adults classified as obese and 45.1% overweight as of 2024.
- The pharmacy retail sector is the clearest signal of where this is heading: a market valued at $7.34 billion in 2024, pacing toward $12.67 billion by 2030, with new retail formats.
- Vision 2030’s $65 billion healthcare commitment and the parallel $45 billion wellness economy are being driven by the same health care consumer. Earning a lasting position in this market means building for what that consumer needs and not treating health as a category extension of an existing retail model.
Saudi Arabia’s healthcare transformation is happening from both ends at once. Vision 2030 has committed over $65 billion to healthcare infrastructure, earmarked 295 hospitals for privatization, and set a target of raising private sector participation from 40% to 65% by 2030. The consumers, meanwhile, have built their own relationship with healthcare.
According to EY’s 2026 survey of 1,002 Saudi respondents, part of a global study across ten countries, 78% track their health digitally against a global average of 57%. Eighty-eight percent are willing to share wearable and health app data with their providers. Saudi Arabia ranked among the highest of all countries surveyed; a population for whom digital health monitoring has become a default.
What drives this mindset is obvious once you look at the numbers. GASTAT data shows that as of 2024, 23.1% of Saudi adults were classified as obese and 45.1% as overweight. With the Kingdom carrying one of the region’s highest burdens of lifestyle-driven chronic conditions, health has shifted from a back-burner concern into a pressing daily priority. Saudi consumers monitor, research and spend their way toward better outcomes — through pharmacies, health apps, supplements, and retail formats that are steadily absorbing functions that once belonged exclusively to the clinic.
The new point of entry
Saudi Arabia’s pharmacy retail market hit $7.34 billion in 2024 and is pacing toward $12.67 billion, expanding at a solid compound annual rate of 9.53%. Beyond the big headline numbers, what those stats really signal is a deep behavioral shift: local consumers are increasingly treating their neighborhood pharmacy, rather than a clinic or hospital, as their first port of call for everyday health.
The format is changing to match. In February 2025, Aster Pharmacy — the retail arm of Aster DM Healthcare — launched Trio in North Riyadh, its largest store in the GCC at 711 square meters, built around a drive-through health and wellness model. It entered the Saudi market with 15 stores across Riyadh and announced plans for 180 across the country within two to three years. The ambition is explicit: pharmacies are the new healthcare destinations.
The regulatory environment arrived at the same moment. Royal Decree M/195, issued on 3 March 2025, lifted the longstanding restriction on foreign ownership of retail pharmacies — a sector reserved exclusively for Saudi nationals until that point. For international operators who have already built health-retail convergence models elsewhere, Saudi Arabia’s healthcare market is now open.
A global turnaround
Saudi Arabia is not the only market where healthcare is reaching into retail. Deloitte’s 2026 US Health Care Outlook, which surveyed 120 C-suite executives at major health plans and health systems, found that around 80% had named cross-industry partnerships, including with retail, a board and C-suite priority for the year ahead.
The examples are concrete. Best Buy has built hospital-at-home programs connecting home technology with clinical monitoring. Kroger has co-branded services tied directly to health outcomes. Each reflects where healthcare executives believe the system needs to go.
The underlying logic is economic. Only 38% of US healthcare spending goes toward prevention, early detection and overall well-being, according to the same Deloitte report. The system built around hospitals and acute care is expensive and slow. Retail is accessible, trusted and already embedded in daily life. The convergence follows from that gap.
Saudi Arabia’s version of that convergence follows a different logic. In the US, the pressure comes from an overstretched system looking outward for relief. In the Kingdom, it comes from a government mandate and a consumer population that has already changed how it manages health.
The question for retail
Vision 2030 has set the terms. The $65 billion infrastructure commitment, the privatization of 295 hospitals, the target of raising private sector participation to 65% — these are ambitious targets, but they are funded, timed, and already in motion. What they create, collectively, is a healthcare system that will increasingly rely on private operators, retail formats and digital access points to reach a population that is already looking for exactly that.
Running right alongside the formal healthcare system, the broader wellness market is having a massive moment. Ken Research suggests that Saudi wellness economy — stretching across nutrition, preventive care, supplements, and fitness — was valued at $45.13 billion in 2025 and is on track to hit $73.23 billion by 2031. The people powering those numbers are the same everyday consumers checking their vitals on a smartwatch, grabbing prescriptions from a drive-through window, and tapping through apps to compare supplement labels.
In Saudi Arabia’s healthcare landscape, the retailers who earn a durable position will be those who understood what the health care consumer actually needed — convenience, trust, integration, access — and built toward it deliberately, rather than treating health as a category extension of an existing retail model.
That gap, between recognizing a market and genuinely serving it, is where the real competition is taking shape.
